ETF Managers Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,048
| Closed | -$377K | – | 739 |
|
|
2021
Q2 | $377K | Sell |
2,048
-389
| -16% | -$71.6K | 0.01% | 569 |
|
|
2021
Q1 | $374K | Sell |
2,437
-660
| -21% | -$101K | 0.01% | 559 |
|
|
2020
Q4 | $484K | Sell |
3,097
-197
| -6% | -$30.8K | 0.01% | 360 |
|
|
2020
Q3 | $370K | Buy |
+3,294
| New | +$370K | 0.01% | 378 |
|
|
2019
Q3 | – | Sell |
-3,204
| Closed | -$404K | – | 590 |
|
|
2019
Q2 | $404K | Sell |
3,204
-10,448
| -77% | -$1.32M | 0.01% | 263 |
|
|
2019
Q1 | $1.85M | Sell |
13,652
-3,917
| -22% | -$529K | 0.09% | 110 |
|
|
2018
Q4 | $1.71M | Sell |
17,569
-2,485
| -12% | -$242K | 0.08% | 136 |
|
|
2018
Q3 | $2.79M | Buy |
+20,054
| New | +$2.79M | 0.11% | 102 |
|
|
2016
Q1 | $22K | Buy |
+181
| New | +$22K | 0.02% | 449 |
|